BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/24/2025 6:10:13 AM | Browse: 52 | Download: 214
 |
Received |
|
2025-06-09 06:02 |
|
Peer-Review Started |
|
2025-06-09 06:02 |
|
First Decision by Editorial Office Director |
|
2025-06-18 07:24 |
|
Return for Revision |
|
2025-06-18 07:24 |
|
Revised |
|
2025-07-03 09:34 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-09-23 02:46 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-09-23 06:57 |
|
Articles in Press |
|
2025-09-23 06:57 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-10-16 01:08 |
|
Publish the Manuscript Online |
|
2025-10-24 06:10 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Minireviews |
| Article Title |
Expansion strategies for Vδ2 γδT cells in cancer immunotherapy: Activation, cytokines, and culture conditions
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Natalia Lehman and Michal Zarobkiewicz |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Science Center of Poland |
No. 2019/35/N/NZ6/02973 |
|
| Corresponding Author |
Michal Zarobkiewicz, Associate Professor, MD, PhD, Department of Clinical Immunology, Medical University of Lublin, Chodzki 4A, Lublin 20-093, Lubelskie, Poland. michal.zarobkiewicz@umlub.pl |
| Key Words |
Vδ2; γδT; Expansion; Immunotherapy; Zoledronate; N-aminobisphosphonates; Mevalonate pathway |
| Core Tip |
Vδ2 γδT cells hold promise for cancer immunotherapy due to their major histocompatibility complex-independent recognition of phosphoantigens and relative ease of their large scale GMP-compliant expansion in vitro. This mini-review outlines current strategies to optimize Vδ2 T cell expansion, highlighting the roles of stimuli, cytokine combinations, and culture conditions. Emerging insights on direct phosphoantigen stimulation and Toll-like receptor-based co-stimulation are also discussed, offering new avenues to enhance γδT cell yield and functionality for therapeutic use. |
| Publish Date |
2025-10-24 06:10 |
| Citation |
Lehman N, Zarobkiewicz M. Expansion strategies for Vδ2 γδT cells in cancer immunotherapy: Activation, cytokines, and culture conditions. World J Clin Oncol 2025; 16(10): 110466 |
| URL |
https://www.wjgnet.com/2218-4333/full/v16/i10/110466.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v16.i10.110466 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
